1.17 USD
-0.03 (-2.5%)
1.113 USD
-0.06 (-4.87%)
ChartMill assigns a Buy % Consensus number of 80% to NRSN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.73. This target is 902.56% above the current price.
NRSN was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NRSN.
In the previous month the buy percentage consensus was at a similar level.
NRSN was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-24 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-10 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-12 | D. Boral Capital | Initiate | Buy |
| 2024-12-16 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-07-17 | Alliance Global Partners | Initiate | Buy |
| 2022-01-07 | Maxim Group | Initiate | Buy |
NEUROSENSE THERAPEUTICS LTD / NRSN FAQ
What do analysts expect the price target to be for NEUROSENSE THERAPEUTICS LTD (NRSN)?
10 analysts have analysed NRSN and the average price target is 11.73 USD. This implies a price increase of 902.56% is expected in the next year compared to the current price of 1.17.
How do analysts rate NEUROSENSE THERAPEUTICS LTD (NRSN)?
The consensus rating for NEUROSENSE THERAPEUTICS LTD (NRSN) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.